Pharma names may correct if there is a dip in broader market: Deepak Shenoy, Capital Mind

In a chat with ET Now, Deepak Shenoy, Founder, Capital Mind, talks about the pharma space.

ET Now: What about the pharma space? Any specific stock in your mind?

Deepak Shenoy: We are long on a stock called Strides Arcolab. They are announcing a Rs 105 dividend. So that has been quite an interesting stock for us; it is going to merge with Shasun. So, we are long-term long on the stock.

Sun Pharma had some kind of negativity over the weekend, so there may be some pressure. But in general, in the pharma space, when the tide falls, everybody is down. In this week if there is a reaction again on the upside in the overall market, we should see pharma stocks correcting.

But maybe it is just a temporary phase.